That's not an issue right know!,
First thing first . Without green light from the FDA that's certainly no option!
The SP would collapse. Within a few weeks it's down under again.
Koos has to bring in more facts first, convice the Market that a R/S is legitable
....and if it's granted it takes minimal another 7 years before it could be licened by the FDA.
So what has Koos the Market to offer? For the moment I can't find a reason why?
Look at AMBS. The CEO neglected his shareholders. Without good underlied information the CEO thought that a R/S is legitim. What happened? The SP collapsed in a few months time! From the R/S price of $7,00 it went shortly up to $12 and sank untill $0,21 , $0,38 right now. The expectaions are that it will sink to it's deepest point of minimal $0,10!! Which price comes out much lower than the point where it started from before the R/S
You be warned!
